WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006081347) CONTROLLED RELEASE COMPOSITIONS COMPRISING AN ANTIPSYCHOTIC AGENT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/081347    International Application No.:    PCT/US2006/002751
Publication Date: 03.08.2006 International Filing Date: 26.01.2006
IPC:
C07D 281/02 (2006.01), A61K 9/24 (2006.01), A61K 9/22 (2006.01), A61K 9/48 (2006.01), A61K 9/52 (2006.01)
Applicants: ELAN PHARMA INTERNATIONAL LIMITED [IE/IE]; Monksland, Athlone, County Westmeath (IE) (For All Designated States Except US).
LIVERSIDGE, Gary [US/US]; (US) (For US Only).
JENKINS, Scott [US/US]; (US) (For US Only)
Inventors: LIVERSIDGE, Gary; (US).
JENKINS, Scott; (US)
Agent: YAO, Gene; Suite 2600, 1101 Market Street, Philadelphia, PA 19107-2950 (US)
Priority Data:
60/647,311 26.01.2005 US
Title (EN) CONTROLLED RELEASE COMPOSITIONS COMPRISING AN ANTIPSYCHOTIC AGENT
(FR) COMPOSITIONS A LIBERATION REGULEE COMPRENANT UN AGENT ANTIPSYCHOTIQUE
Abstract: front page image
(EN)The invention relates to a formulation for the treatment of acute manic episodes associated with Bipolar I Disorder comprising an antipsychotic agent selected from the group consisting of: a dibenzothiazepine derivative; lithium; and divalproex. The formulation comprises a first component which comprises a first population the antipsychotic agent and at least one subsequent component which comprises a subsequent population of the antipsychotic agent and which allows for the modified release of the agent. The combination of the first and the subsequent components in operation deliver the antipsychotic agent in a pulsed or controlled manner over a period of up to twenty-four hours.
(FR)L'invention concerne une préparation destinée au traitement d'épisodes maniaques aigus associés au trouble bipolaire I et comprenant un agent antipsychotique choisi dans le groupe constitué par un dérivé de dibenzothiazépine, du lithium et du divalproex. Cette préparation comprend un premier constituant renfermant une première population de l'agent psychotique et au moins un second constituant renfermant une seconde population de l'agent antipsychotique et permettant une libération modifiée de l'agent. La combinaison desdits premier et second constituants lors d'une utilisation permet d'administrer l'agent antipsychotique de manière pulsée ou régulée sur une période pouvant atteindre 24 heures.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)